WallStreetZenWallStreetZen

NASDAQ: IOBT
Io Biotech Inc Stock Forecast, Predictions & Price Target

OverviewForecast
EarningsRevenueDividendOwnership

Analyst price target for IOBT

Based on 3 analysts offering 12 month price targets for Io Biotech Inc

Min Forecast
$6.00+574.16%
Avg Forecast
$9.33+948.65%
Max Forecast
$12.00+1,248.31%

Should I buy or sell IOBT stock?

Based on 3 analysts offering ratings for Io Biotech Inc.

Strong Buy
Strong Buy
2 analysts 66.67%
Buy
1 analysts 33.33%
Hold
0 analysts 0%
Sell
0 analysts 0%
Strong Sell
0 analysts 0%

Be the first to know when Wall Street analysts revise their IOBT stock forecasts and price targets.

IOBT stock forecasts by analyst

Analyst / FirmRatingActionPrice TargetUpside/DownsideDateAnalyst Color
lockedlocked$00.00+00.00%2024-11-12
lockedlocked$00.00+00.00%2024-09-16Find Out Why
lockedlocked$00.00+00.00%2024-09-03

1 of 1

Forecast return on equity

Is IOBT forecast to generate an efficient return?

Company
-61.44%
Industry
138.05%
Market
70.76%
IOBT's Return on Equity is... subscribe to Premium to read more.
Forecast High Return on Equity Forecast

Forecast return on assets

Is IOBT forecast to generate an efficient return on assets?

Company
-49.57%
Industry
22.54%
IOBT is forecast to generate... subscribe to Premium to read more.
Forecast Return on Assets vs Industry Forecast

IOBT earnings per share forecast

What is IOBT's earnings per share in the next 3 years based on estimates from 4 analysts?

Avg 1 year Forecast
-$1.35
Avg 2 year Forecast
-$1.32
Avg 3 year Forecast
-$1.10

IOBT revenue forecast

What is IOBT's revenue in the next 3 years based on estimates from 1 analyst?

Avg 1 year Forecast
$4.7M
Avg 2 year Forecast
$23.3M
Avg 3 year Forecast
$81.5M

IOBT vs Biotech Stocks

TickerPricePrice TargetUp/downsideConsensus
IOBT$0.89$9.33+948.65%Strong Buy
FBIO$2.13$26.00+1,120.66%Buy
CNTB$1.06$8.00+654.72%Buy
VRCA$1.28$8.00+525.00%Buy
CASI$3.80N/AN/A
View Top Biotech Stocks

Io Biotech Stock Forecast FAQ

Is Io Biotech Stock a good buy in 2024, according to Wall Street analysts?

The consensus among 3 Wall Street analysts covering (NASDAQ: IOBT) stock is to Strong Buy IOBT stock.

Out of 3 analysts, 2 (66.67%) are recommending IOBT as a Strong Buy, 1 (33.33%) are recommending IOBT as a Buy, 0 (0%) are recommending IOBT as a Hold, 0 (0%) are recommending IOBT as a Sell, and 0 (0%) are recommending IOBT as a Strong Sell.

If you're new to stock investing, here's how to buy Io Biotech stock.

What is IOBT's earnings growth forecast for 2024-2026?

(NASDAQ: IOBT) Io Biotech's forecast annual earnings growth rate of N/A is not forecast to beat the US Biotechnology industry's average forecast earnings growth rate of 11.89%, and while it is not forecast to beat the US market's average forecast earnings growth rate of 17.58%.

Io Biotech's earnings in 2024 is -$90,340,000.On average, 4 Wall Street analysts forecast IOBT's earnings for 2024 to be -$89,103,936, with the lowest IOBT earnings forecast at -$92,892,089, and the highest IOBT earnings forecast at -$85,645,188. On average, 4 Wall Street analysts forecast IOBT's earnings for 2025 to be -$86,633,402, with the lowest IOBT earnings forecast at -$98,821,371, and the highest IOBT earnings forecast at -$67,857,341.

In 2026, IOBT is forecast to generate -$72,139,601 in earnings, with the lowest earnings forecast at -$99,480,180 and the highest earnings forecast at -$53,363,540.

What is IOBT's revenue growth forecast for 2025-2027?

(NASDAQ: IOBT) Io Biotech's forecast annual revenue growth rate of N/A is not forecast to beat the US Biotechnology industry's average forecast revenue growth rate of 34.8%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 8.83%.

Io Biotech's revenue in 2024 is $0.On average, 1 Wall Street analysts forecast IOBT's revenue for 2025 to be $309,640,296, with the lowest IOBT revenue forecast at $309,640,296, and the highest IOBT revenue forecast at $309,640,296. On average, 4 Wall Street analysts forecast IOBT's revenue for 2026 to be $1,536,408,795, with the lowest IOBT revenue forecast at $309,640,296, and the highest IOBT revenue forecast at $3,062,540,168.

In 2027, IOBT is forecast to generate $5,370,348,586 in revenue, with the lowest revenue forecast at $1,600,906,210 and the highest revenue forecast at $8,627,105,688.

What is IOBT's forecast return on assets (ROA) for 2024-2027?

(NASDAQ: IOBT) forecast ROA is -49.57%, which is lower than the forecast US Biotechnology industry average of 22.54%.

What is IOBT's Price Target?

According to 3 Wall Street analysts that have issued a 1 year IOBT price target, the average IOBT price target is $9.33, with the highest IOBT stock price forecast at $12.00 and the lowest IOBT stock price forecast at $6.00.

On average, Wall Street analysts predict that Io Biotech's share price could reach $9.33 by Nov 12, 2025. The average Io Biotech stock price prediction forecasts a potential upside of 948.65% from the current IOBT share price of $0.89.

What is IOBT's Earnings Per Share (EPS) forecast for 2024-2026?

(NASDAQ: IOBT) Io Biotech's current Earnings Per Share (EPS) is -$1.29. On average, analysts forecast that IOBT's EPS will be -$1.35 for 2024, with the lowest EPS forecast at -$1.41, and the highest EPS forecast at -$1.30. On average, analysts forecast that IOBT's EPS will be -$1.32 for 2025, with the lowest EPS forecast at -$1.50, and the highest EPS forecast at -$1.03. In 2026, IOBT's EPS is forecast to hit -$1.10 (min: -$1.51, max: -$0.81).

What is IOBT's forecast return on equity (ROE) for 2024-2027?

(NASDAQ: IOBT) forecast ROE is -61.44%, which is considered weak.
©2024 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.